Home
About
Investors
- Investment Philosophy
- Client Portal
Corporates
Listed
Unlisted
- DekkoSecure
- Lava Blue
News
Contact
- Contact Us
- Newsletter
Open an Account

Sateva Acquisition Progress

Jan 21, 2021

ASX News K2Fly

Send
Share
Share

Related Posts

Incannex partners with the UWA Centre for Sleep Science to uprate the IHL-42X clinical trial to a multi-site study

May 11, 2021 |

ASX News, Incannex Healthcare (ASX:IHL)

Incannex Engages Curia to Scale-up Manufacture of cGMP IHL-216A

Aug 2, 2022 |

ASX News, Incannex Healthcare (ASX:IHL)

corporate-advisor-paul-hart

Bulls, Bears & Brokers: Canary Capital’s Paul Hart on hot market sectors

Jul 18, 2019 |

ASX News, General News

Incannex submits HREC proposal and FDA pre-IND meeting request for Psi-GAD psilocybin therapy for Generalised Anxiety Disorder

Aug 13, 2021 |

ASX News, Incannex Healthcare (ASX:IHL)

GET INVESTMENT OPPORTUNITIES OR
RAISE CAPITAL

Contact Us

Home
About
Investors
- Investment Philosophy
Corporates

Listed
Unlisted
- DekkoSecure
- Lava Blue

Latest News
Contact

CANARY CAPITAL PTY LTD

ABN 18 618 657 640
CAR number 1254859
Of BR Securities Australia Pty Ltd
Holder of AFSL 456663
Level 5/20 Bond St,
Sydney NSW 2000,
AUSTRALIA

P: (02) 9133 1325

Privacy Policy
Terms of Service
Disclaimer
Financial Services Guide

© 2025 Canary Capital | Web Development by Argon